Skip to main content
SpringerLink
Log in

Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

We investigated the effect of VIP on the liver metastases and angiogenesis by Colon 26-L5 carcinoma cells in mice. Daily systemic administration of VIP, beginning 3 days after tumor inoculation into a portal vein of mice, inhibited significantly the development of their liver metastases. Immunohistochemical staining for factor VIII-related antigen in the sections of liver metastases showed that the systemic administration of VIP caused significant prevention of angiogenesis within tumor masses. VIP (10−10 to 10−6 M) inhibited the invasion of reconstituted basement membrane (Matrigel) by hepatic sinusoidal endothelial (HSE) cells in a concentration-dependent manner in a Transwell chamber assay in vitro and achieved approximately 50% reduction of control at 10−6 M. VIP (10−6 M) also significantly suppressed the haptotactic migration of HSE cells to fibronectin, laminin or type I collagen substrates with a similar inhibition rate to the invasion assay. Exposure of VIP to HSE cells induced accumulation of intracellular cAMP in a concentration-dependent manner. The inhibitory effect of VIP (10−6 M) on HSE cell migration was significantly abrogated in the presence of 3×10−6 M H-89, a cAMP-dependent protein kinase inhibitor. VIP (10−6 M) inhibited the morphogenesis of HSE cells into capillary-like structures on Matrigel-coated wells. VIP did not affect the proliferation of HSE cells and the production of gelatinases in HSE cells in vitro at the concentrations used in the invasion assay. These observations suggest that the anti-metastatic effect of VIP on liver metastases by Colon 26-L5 carcinoma cells in mice is partly due to the prevention of tumor angiogenesis probably through suppression of the motility of endothelial cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Folkman J, Cotran. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976; 16: 207–48.

    Google Scholar 

  2. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial award lecture. Cancer Res 1986; 46: 467–73.

    Google Scholar 

  3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931–4.

    Google Scholar 

  4. O'Reilly MS, Holmgren L, Shing Y et al. Angiostatin: a novel angiogenesis inhibitor that mediate the suppression of metastases by a lewis lung carcinoma. Cell 1994; 79: 315–28.

    Google Scholar 

  5. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K et al. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 1994; 54: 6504–11.

    Google Scholar 

  6. Kolber DL, Knisely TL, Maione TE. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J Natl Cancer Inst 1995; 87: 304–9.

    Google Scholar 

  7. Arenberg DA, Kunkol SL, Polverini PJ et al. Interferon-gammainducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small call lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 1996; 184: 981–92.

    Google Scholar 

  8. O'Reilly MS, Boehm T, Shing Y et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277–85.

    Google Scholar 

  9. Dinney CPN, Bielenberg DR, Perrote P et al. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human carcinoma in mice by systemic interferon-alpha administration. Cancer Res 1998; 58: 808–14.

    Google Scholar 

  10. Xie K, Fidler IJ. Therapy of cancer metastasis by activation of the inducible nitric oxide synthetase. Cancer Metastasis Rev 1998; 17: 55–75.

    Google Scholar 

  11. Said SI, Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature 1970; 225: 863–4.

    Google Scholar 

  12. Said SI, Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 1970; 169: 1217–8.

    Google Scholar 

  13. Giachetti A, Said SL, Reynolds RC, Koniges FC. Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci USA 1977; 74: 3424–8.

    Google Scholar 

  14. Krejs GJ, Fordtran JS, Bloom SR et al. Effect of VIP infusion on water and ion transport in the human jejunum. Gastroenterology 1980; 78: 722–7.

    Google Scholar 

  15. Itoh H, Lederis KP, Rorstad OP. Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide. Eur J Pharmacol 1990; 18: 199–205.

    Google Scholar 

  16. Ahren B, Alumets J, Ericsson M et al. VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion. Nature 1980; 287: 343–5.

    Google Scholar 

  17. Johnston JA, Taub DD, Lloyd AR et al. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol 1994; 153: 1762–8.

    Google Scholar 

  18. Ishioka C, Yoshida A, Kimata H, Mikawa H. Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells. Clin Exp Immunol 1992; 87: 504–8.

    Google Scholar 

  19. Ogasawara M, Murata J, Ayukawa K, Saiki I. Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro. Cancer Lett 1997; 116: 111–6.

    Google Scholar 

  20. Oasawara M, Murata J, Ayukawa K, Saiki I. Inhibitory effect of vasoactive intestinal polypeptide (VIP) on experimental liver metastasis bymurine Colon 26-L5 carcinoma cells. Oncol Res 1998; 10: 361–70.

    Google Scholar 

  21. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991: 64: 327–36.

    Google Scholar 

  22. Ohnishi Y, Sakamoto T, Fujii H et al. Characterization of a liver metastatic variant of murine Colon 26 carcinoma cells. Tumor Biol 1997; 18: 113–22.

    Google Scholar 

  23. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis andmetastasis: correlation in invasive breast carcinoma. N Engl JMed 1991; 324: 1–8.

    Google Scholar 

  24. Saiki I, Murata J, Watanabe K et al. Inhibition of tumor cell invasion by Ubenimex (Bestatin) in vitro. Jpn J Cancer Res 1989: 80: 873–8.

    Google Scholar 

  25. Ata N, Oku T, Hattori M et al. Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinasemediated degaradation of type IV collagens by metastatic tumor cells. Oncol Res 1996; 8: 503–11.

    Google Scholar 

  26. Cid MC, Grant DS, Hoffman GS et al. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993; 91: 977–85.

    Google Scholar 

  27. Tanigawa N, Lu C, Mitsui T, Miura S. Quantification of sinusoidlike vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 1997; 26: 1216–23.

    Google Scholar 

  28. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and co-polymerized substrates. Anal Biochem 1980; 102: 196–202.

    Google Scholar 

  29. Sreedharan SP, Robichon A, Peterson KE, Goetzl EJ. Cloning and expression of the human vasoactive intestinal peptide receptor. Proc Natl Acad Sci USA 1991; 88: 4986–90.

    Google Scholar 

  30. Lampugnani MG, Giorgi M, Gaboli M et al. Endothelial cell motility, integrin receptor clustering, and microfilament organization are inhibited by agents that increase intracellular cAMP. Lab Invest 1990; 63: 521–31.

    Google Scholar 

  31. Dong J-M, Leung T, Manser E, Lim L. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROK±. J Biol Chem 1998; 273: 22554–62.

    Google Scholar 

  32. Lang P, Gesbert F, Delespine-Carmagnat M et al. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cytotoxic lymphocytes. EMBO J 1996; 15: 510–9.

    Google Scholar 

  33. Singh RK, Tsan R, Radinsky R. Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis. Clin Exp Metastasis 1997; 15: 140–50.

    Google Scholar 

  34. Liotta, LA. Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986; 46: 1–7.

    Google Scholar 

  35. Villablanca AC, Murphy CJ, Reid TW. Growth-promoting effects of substance P on endothelial cells in vitro: synergism with calcitonin gene-related peptide, insulin, and plasma factors. Circ Res, 1994; 75: 1113–20.

    Google Scholar 

  36. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 1998; 83: 187–95.

    Google Scholar 

  37. Barrie R, Woltering EA, Hajarizadeh H et al. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J Surg Res 1993: 55: 446–50.

    Google Scholar 

  38. Woltering EA, Barrie R, O'Dorisio TM et al. Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J Surg Res 1991; 50: 245–51.

    Google Scholar 

  39. Qin Y, Cauteren MV, Osteaux M et al. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance. Cancer Res 1992; 52: 6025–30.

    Google Scholar 

  40. Hegerstrand A, Dalsgaard C-J, Jonzon B et al. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 1990; 87: 3299–303.

    Google Scholar 

  41. Kahler CM, Kirchmair, R, Kaufmann G et al. Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro. Arteriosclerosis, Thromb Vasc Biol 1997; 17: 932–9.

    Google Scholar 

  42. Staren ED, Gould VE, Jansson DS et al. Neuroendocrine differentiation in poorly differentiated colon carcinomas. Am Surg 1990; 56: 412–9.

    Google Scholar 

  43. Noordzij MA, van Steenbrugge GJ, van der Kwast TH et al. Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate. Urol Res 1995; 22: 333–41.

    Google Scholar 

  44. de Bruine AP, Wiggers T, Beek C et al. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int J Cancer 1993; 54: 765–71.

    Google Scholar 

  45. Ghanem G, Lienard D, Hanson P et al. Increased serum alphamelanocyte stimulating hormone (alpha-MSH) in human malignant melanoma. Eur J Cancer Clin Oncol 1986; 22: 535–6.

    Google Scholar 

  46. Frucht H, Gazdar AF, Park J-A et al. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 1992; 52: 1114–22.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathogenic Biochemistry, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, Toyama, 930-0194, Japan

    Masaru Ogasawara, Jun Murata, Yukio Kamitani, Kazuko Hayashi & Ikuo Saiki

Authors
  1. Masaru Ogasawara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Murata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yukio Kamitani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuko Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ikuo Saiki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ogasawara, M., Murata, J., Kamitani, Y. et al. Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver. Clin Exp Metastasis 17, 283–291 (1999). https://doi.org/10.1023/A:1006648402164

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006648402164

Search

Navigation